I come back to my point: allowing for the fact that it applies only to paragraph 38(1)(c), does that mean that people whose common-law partners may have active AIDS, or if not AIDS, then HIV—if you want to make the distinction, because AIDS could be regarded as a potential excessive demand on the health system, whereas HIV might not be.How do you work that?

A classification system, which uses H and N types of protein receptors on the coding of the virus, provides for 16 H types and 9 N types and the multiple combinations associated with that of the virus.

- active substance: recombinant vector, virus, naked or complex plasmids, virus producing cells, in vitro genetically modified cells.

(d) pathogenicity: infectivity, toxigenicity, virulence, allergenicity, carrier (vector) of pathogen, possible vectors, host range including non-target organism. Possible activation of latent viruses (proviruses). Ability to colonise other organisms.

(d)pathogenicity: infectivity, toxigenicity, virulence, allergenicity, carrier (vector) of pathogen, possible vectors, host range including non-target organism. Possible activation of latent viruses (proviruses). Ability to colonise other organisms.

However, while more and more has become known about the clinical aspects of the disease, little progress had been made with regard to its treatment by 1986. ----------- (1) LAV : lymphadenopathy associated virus (2) human T-lymphocite virus (3) human immunodeficiency virus - 2 - The European conference on the clinical aspects of AIDS will devote ample discussion to the neurological manifestations of the disease, its pulmonary manifestations, cerebral manifestations, its effect on the skin, AIDS-related cancers, psychological and sociological problems, etc.